Project Description

The 15 winners from Regional Innovation Scheme countries receive EUR 25 000 in smart money, training and mentoring
The Regional Innovation Scheme Programme (RIS) focuses on countries from Central, Eastern and Southern Europe. The 15 EIT Health InnoStars Awards winner are still developing in terms of healthcare innovation. They will receive EUR 25 000 in funding, as well as training and mentoring support.

EIT Health InnoStars Awards
In the third year of the InnoStars Awards, the winners were chosen from 116 high-quality contestants based in the 13 RIS countries – which have more moderate levels of innovation than other European countries.

Selected by a panel of experts, the winning start-ups include five from Portugal, two from Poland, two from Hungary, two from Latvia, one from the Czech Republic, one from Lithuania, one from Italy and one from Romania.

They will receive EUR 25 000 of smart money, individual mentoring for four months, and the opportunity to participate in two bootcamps in Europe. EIT Health InnoStars will also organise three validation interviews with potential customers, investors and partners for the award winners. After the four-month programme, 10 finalists will be selected to participate in the InnoStars Awards final pitch in November, to compete for the three top prizes: an additional EUR 25 000, EUR 15 000, or EUR 10 000 in funding.

Increasing success in RIS countries
More and more start-ups from the regions covered by the Regional Innovation Scheme apply successfully for prestigious European innovation programmes like InnoStars Awards. There is an impressive talent pool in this part of Europe, that has skills and knowledge to create and develop healthcare innovations.

Monika Toth, EIT Health InnoStars RIS Programme Manager

The EIT Health InnoStars Awards Programme is open for micro and small enterprises, spin-offs and start-ups that already have a prototype or a Minimum Viable Product (MVP). All contestants must come from the RIS countries, and based on the increasing number of qualified applicants, the talent pool there is strong.

There are excellent science and talented teams being produced in Eastern Europe, Mediterranean countries and Portugal. InnoStars Awards provides start-ups from these countries with funds to further validate their health solutions, education on how to create a business plan and a chance to talk with investors and connect with expert mentors in other European regions that can share their network and experience.

Dr Nuno Viegas, Business Creation Manager, EIT Health InnoStars

List of InnoStars Award winners for 2019
B-CULTURE: A Portuguese start-up develops 4D in-vitro human tissue models for drug testing. They offer an efficient and ethical solution for a monitored screening and validation of compounds and implants for the pharma, dental and biomedical industries.

BrachyDOSE: A Lithuanian team of experienced engineers and scientists offer a cancer treatment quality control tool that provides more effective and personalised treatment. Their product is made for oncologists who are seeking precision and the best possible treatment results in radiotherapy.

BRIGHT – Beyond Research and Information Graphics for Health and Technology: An innovative company from Portugal offers the Serious Games for Health project, which helps patients to self-manage their disease and promotes adherence to therapy.

Femyo: A Romanian company was created to cut the at-birth and infant mortality rate in Europe by half. The company seeks to achieve this by building the first digital health management organisation in Europe, to ensure that all their subscribers give the best start in life to their children.

HydrUStent: The Portuguese start-up is developing a portable, wireless and less invasive Urodynamics testing technology that allows long-term continuous monitoring of intra-urinary pressures. This will positively impact patient’s lives by lessening the discomfort associated with this type of testing, currently performed only in clinical settings.

InoCure: The bionanotechnology company from the Czech Republic delivers solutions for life science and pharmaceutical industry. Its product DifMATRIX is the first active 3D cell culture membrane that enables faster, reliable and ethical preclinical testing.

InSimu Patient: This innovation from Hungary is a medical case study educational app that provides learners with simulated patients. The app helps medical students and physicians gain clinical experience by making decisions on their own to treat simulated, virtual patients. Mimicking all possible aspects of real-life diagnostics, InSimu changes the way young doctors think and learn.

Mosaic Software Srl: An innovative start-up from Italy transforming clinical research by virtue of a focus on patient centricity and forefront digital technologies. Their PatchAI is the first cognitive platform for the collection and predictive analysis of patient-reported data in clinical trials, embedding an AI-powered virtual assistant mimicking human empathetic conversations to engage and motivate patients and increase protocol compliance.

Mhydrogel: A chemical start-up based in Latvia offers therapeutic contact lenses to save eyesight after a chemical eye injury.